Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Papp
阿达木单抗在斑块型银屑病成人患者中的长期安全性
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Continuous Every 2-Week Dosing of Ixekizumab Over 52 Weeks in Patients With Moderate-To-Severe Plaque Psoriasis in a Randomized Phase 3 Trial (IXORA-P)
British Journal of Dermatology
Dermatology
Medicine
060 Integrated Safety of Ixekizumab in Patients With Moderate-To-Severe Psoriasis: Results From a Pooled Analysis of 7 Clinical Trials
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
059 Ixekizumab Shows No Association With MACE in Patients With Moderate-To-Severe Psoriasis: An Integrated Safety Analysis of Clinical Trials
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Management of Egfr Tki–induced Dermatologic Adverse Events
Current Oncology
Oncology
